— Financial reporting — Consolidated statement of comprehensive income
Consolidated statement of comprehensive income
January 1 – June 30
millions of CHF |
|
Notes |
|
2023 |
|
2022 1) |
|
Net income |
|
|
|
7.3 |
|
9.2 |
|
|
|
|
|
|
|
|
|
Items that may be reclassified subsequently to the income statement |
|
|
|
|
|
|
|
Cash flow hedges, net of tax |
|
|
|
0.6 |
|
–0.5 |
|
Currency translation differences |
|
|
|
–3.2 |
|
–8.0 |
|
Total items that may be reclassified subsequently to the income statement |
|
|
|
–2.6 |
|
–8.5 |
|
|
|
|
|
|
|
|
|
Items that will not be reclassified to the income statement |
|
|
|
|
|
|
|
Remeasurements of defined benefit plans, net of tax |
|
|
|
–0.3 |
|
–5.4 |
|
Total items that will not be reclassified to the income statement |
|
|
|
–0.3 |
|
–5.4 |
|
|
|
|
|
|
|
|
|
Total other comprehensive income |
|
|
|
–2.9 |
|
–13.9 |
|
|
|
|
|
|
|
|
|
Total comprehensive income for the period |
|
|
|
4.4 |
|
–4.7 |
|
1) The numbers as of June 30, 2022, have been adjusted following the deconsolidation of medmix Poland. A reconciliation to the previously published numbers is provided in note 14.